These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20113257)

  • 21. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction.
    Downie PF; Talwar S; Squire IB; Davies JE; Barnett DB; Ng LL
    Clin Sci (Lond); 1999 Sep; 97(3):255-8. PubMed ID: 10464049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of storage conditions on measurements of canine N-terminal pro-B-type natriuretic peptide.
    Hezzell MJ; Boswood A; Lötter N; Elliott J
    J Vet Cardiol; 2015 Mar; 17(1):34-41. PubMed ID: 25547663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immulite 2000 parathyroid hormone assay: stability of parathyroid hormone in EDTA blood kept at room temperature for 48 h.
    Omar H; Chamberlin A; Walker V; Wood PJ
    Ann Clin Biochem; 2001 Sep; 38(Pt 5):561-3. PubMed ID: 11587137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of nitric oxide-related amino acids in serum and plasma: effects of blood clotting and type of anticoagulant.
    Davids M; Peters JH; de Jong S; Teerlink T
    Clin Chim Acta; 2013 Jun; 421():164-7. PubMed ID: 23518295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma B-type natriuretic peptide (BNP) measuring].
    Ashizawa N; Yano K
    Nihon Rinsho; 2006 May; 64(5):861-4. PubMed ID: 16689366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study.
    Bionda C; Bergerot C; Ardail D; Rodriguez-Lafrasse C; Rousson R
    Ann Clin Lab Sci; 2006; 36(3):299-306. PubMed ID: 16951271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men.
    Ohba H; Takada H; Musha H; Nagashima J; Mori N; Awaya T; Omiya K; Murayama M
    Am Heart J; 2001 May; 141(5):751-8. PubMed ID: 11320362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones.
    Evans MJ; Livesey JH; Ellis MJ; Yandle TG
    Clin Biochem; 2001 Mar; 34(2):107-12. PubMed ID: 11311219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide.
    Holt RI; Erotokritou-Mulligan I; Ridley SA; McHugh CM; Bassett EE; Cowan DA; Bartlett C; Sönksen PH
    Growth Horm IGF Res; 2009 Feb; 19(1):43-50. PubMed ID: 18617430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study.
    Conlon CM; Dawkins I; O'Loughlin C; Gibson D; Kelleher CC; Ledwidge M; McDonald K
    Clin Chem Lab Med; 2011 Apr; 49(4):719-28. PubMed ID: 21275814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population.
    Alehagen U; Lindstedt G; Levin LA; Dahlström U
    Int J Cardiol; 2005 Apr; 100(1):125-33. PubMed ID: 15820295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.
    Gill D; Seidler T; Troughton RW; Yandle TG; Frampton CM; Richards M; Lainchbury JG; Nicholls G
    Clin Sci (Lond); 2004 Feb; 106(2):135-9. PubMed ID: 12974669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
    López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
    Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.
    Niederkofler EE; Kiernan UA; O'Rear J; Menon S; Saghir S; Protter AA; Nelson RW; Schellenberger U
    Circ Heart Fail; 2008 Nov; 1(4):258-64. PubMed ID: 19808300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
    Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis.
    Suzuki S; Yoshimura M; Nakayama M; Mizuno Y; Harada E; Ito T; Nakamura S; Abe K; Yamamuro M; Sakamoto T; Saito Y; Nakao K; Yasue H; Ogawa H
    Circulation; 2004 Sep; 110(11):1387-91. PubMed ID: 15353502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
    Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
    Pedersen EB; Bacevicius E; Bech JN; Solling K; Pedersen HB
    Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.